Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When the lymphocyte loses its clothes.

Nada Nekrep1, Joseph D Fontes, Matthias Geyer

  • 1Institute of Biochemistry, Medical Faculty of the University of Ljubljana, Slovenia.

Immunity
|April 23, 2003
PubMed
Summary

Type II bare lymphocyte syndrome (BLS), a severe combined immunodeficiency, involves absent MHCII expression due to mutations. All genetic complementation groups are now identified, offering insights into immune response genetics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

C-terminal lysine residues localise NLRP10 at lipid droplets and govern NLRP10 oligomer formation.

EMBO reports·2026
Same author

Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.

Human molecular genetics·2026
Same author

Non-decameric NLRP3 reveals a TGN/MTOC-distal pathway of inflammasome activation.

Nature communications·2026
Same author

Nests in an egg cell: structures of protein-storage units in oocytes.

Nature·2026
Same author

ACEing Cognitive Integration: Evidence from a Structural Equation Model.

Teaching and learning in medicine·2026
Same author

Contemporary Step 1 Predictive Methods Across 12 US MD-Granting Medical Schools.

Teaching and learning in medicine·2026

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Type II bare lymphocyte syndrome (BLS), also known as major histocompatibility complex class II (MHCII) deficiency, is a severe combined immunodeficiency (SCID).
  • It is characterized by the lack of MHCII molecule expression on immune cells, which is crucial for adaptive immunity.
  • Previously, four complementation groups of BLS were identified, indicating genetic heterogeneity.

Purpose of the Study:

  • To account for all previously defined complementation groups in Type II BLS.
  • To elucidate the genetic basis of MHCII deficiency.
  • To understand the implications of specific mutations for immune response genetics.

Main Methods:

  • Genetic analysis of patients with Type II BLS.

Related Experiment Videos

  • Identification of mutations in genes encoding DNA-bound activators and coactivators for MHCII transcription.
  • Complementation studies to group patients based on genetic defects.

    • Main Results:

    • All known complementation groups of Type II BLS have been identified and accounted for.
    • Mutations identified in DNA-bound activators and the coactivator for MHCII transcription are responsible for the disease.
    • Specific mutations provide insights into the regulatory pathways of MHCII expression.

    Conclusions:

    • The genetic basis of Type II BLS is now fully elucidated, with all complementation groups identified.
    • Understanding these genetic defects offers critical insights into the complex regulation of the immune response.
    • Further studies on BLS and its mutations are valuable for advancing the field of immunogenetics.